http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2802937-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
filingDate 2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a70a8fdeebe21cdbc419ce395b14b19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37d7c0915e7ac42e466da607850528f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7d0e0d4c78ba0a7e052fa0e9dcd380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b067f402e4c0c4939e67e09876ab19f
publicationDate 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2802937-A1
titleOfInvention Polymorphs of febuxostat
abstract The present invention relates to crystalline form I of Febuxostat as well as to pharmaceutical compositions comprising crystalline form I as an active pharmaceutical ingredient. Furthermore the present invention relates to a further polymorphic form of Febuxostat designated as form II and to a novel solvate of Febuxostat. The present invention also relates to methods of making crystalline form I, form II and the novel solvate of Febuxostat.
priorityDate 2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721

Total number of triples: 21.